Juejing Ling, MSc

IQVIA Solutions Canada Inc., Canada

Disclosure(s): GSK: Employee of IQVIA , a company that receives consulting fees from GSK.

Poster(s):

• 1252 - A Real-World Observational Study on HIV-Infected Patients who Switched from Nevirapine + 2 Nucleoside Reverse Transcriptase Inhibitors to Dolutegravir/Lamivudine in British Columbia, Canada
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET